Efficacy & Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme After Complete Surgical Resection
NCT01006044
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Interventions
BIOLOGICAL:
autologous dendritic cells
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra